We protect your health through science
Investigation
Viral Pathogenesis and Immunity
Publications
Nrf2 plays a protective role against intravascular hemolysis-mediated acute kidney injury.
Rubio-Navarro A, Vázquez-Carballo C, Guerrero-Hue M, García-Caballero C, Herencia C, Gutierrez E, Yuste C, Sevillano A, Praga M, Egea J, Cannata P, Cortegano I, de Andrés B, Gaspar ML, Cadenas S, Michalska P, León R, Ortiz, A, Egido J, Moreno JA. Front Pharmacol. 2019; 10: 740.
PUBMED DOIMultidrug-resistant gram-negative bacteria in Spanish ICU patients: clinical and microbiological characterization (MURAN-UCI Project).
9. Multidrug-resistant gram-negative bacteria in Spanish ICU patients: clinical and microbiological characterization (MURAN-UCI Project). Autores: Ramirez de Arellano E, López-Causapé C, Delgado-Valverde M, Arroyo Muñoz FJ, Alemparte-Pardavila E, Arca-Suárez J, Ayestarán I, Calvo Montes J, Cañada-Garcia J, Garcia-Cobos S, García-Fernández S, Gijón Cordero D, González-López JJ, Mir-Cros A, Nuvials X, Pérez-Vázquez M, Pomares-de la Peña A, Pampín-Garcia M, Riazzo C, Rodríguez-Gómez J, Rojo-Molinero E, Ruiz-Garbajosa P, Soriano C, Suberviola Cañas B, Taltavull B, Garnacho-Montero J, Oliver Palomo A, Oteo-Iglesias J; MURAN-UCI Spanish group. Revista: Microbiol Spectr. 2026 Feb 3;14(2):e0298725.
PUBMED DOIBroth microdilution protocol for determining antimicrobial susceptibility of Legionella pneumophila to clinically relevant antimicrobials
Sewell M, Farley C, Portal EAR, Lindsay D, Ricci ML, Jarraud S, Scaturro M, Descours G, Krøvel AV, Barton R, Boostom I, Ure R, Kese D, Gaia V, Golob M, Paukner S, Ginevra C, Afshar B, Nadarajah S, Wybo I, Michel C, Echahdi F, González-Rubio JM, González-Camacho F, Mentasti M, Flountzi AS, Petzold M, Moran-Gilad J, Uldum S, Winchell J, Wooton M, Bernard K, Jones LC, Chalker VJ, Spiller OB. J Microbiol Methods. 2025 Jan;228:107071.
PUBMED DOITrends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium
Shaw D, Abad R, Amin-Chowdhury Z, Bautista A, Bennett D, Broughton K, Cao B, Casanova C, Choi EH, Chu YW, Claus H, Coelho J, Corcoran M, Cottrell S, Cunney R, Cuypers L, Dalby T, Davies H, de Gouveia L, Deghmane AE, Demczuk W, Desmet S, Domenech M, Drew R, du Plessis M, Duarte C, Erlendsdóttir H, Fry NK, Fuursted K, Hale T, Henares D, Henriques-Normark B, Hilty M, Hoffmann S, Humphreys H, Ip M, Jacobsson S, Johnson C, Johnston J, Jolley KA, Kawabata A, Kozakova J, Kristinsson KG, Krizova P, Kuch A, Ladhani S, Lâm TT, León ME, Lindholm L, Litt D, Maiden MCJ, Martin I, Martiny D, Mattheus W, McCarthy ND, Meehan M, Meiring S, Mölling P, Morfeldt E, Morgan J, Mulhall R, Muñoz-Almagro C, Murdoch D, Murphy J, Musilek M, Mzabi A, Novakova L, Oftadeh S, Perez-Argüello A, Pérez-Vázquez M, Perrin M, Perry M, Prevost B, Roberts M, Rokney A, Ron M, Sanabria OM, Scott KJ, Sheppard C, Siira L, Sintchenko V, Skoczyńska A, Sloan M, Slotved HC, Smith AJ, Steens A, Taha MK, Toropainen M, Tzanakaki G, Vainio A, van der Linden MPG, van Sorge NM, Varon E, Vohrnova S, von Gottberg A, Yuste J, Zanella R, Zhou F, Brueggemann AB. Lancet Digit Health. 2023 Sep;5(9):e582-e593.
PUBMED DOIPaenibacillus spp. isolated from human and environmental samples in Spain: detection of 11 new species.
Sáez-Nieto JA, Medina-Pascual MJ, Carrasco G, Garrido N, Fernandez-Torres MA, Villalón P, Valdezate S. Paenibacillus spp. isolated from human and environmental samples in Spain: detection of 11 new species. New Microbes New Infect. 2017. 24;19:19-27.
PUBMED DOIAdditional Information
The activity of this unit focuses on the development and clinical validation of point-of-care diagnostic methodology against liver viruses based on an emerging field, nanotechnology, a line of research that is developed in collaboration with BioAssays SL. Likewise, this unit focuses on delving into the immuno-virological mechanisms underlying viral infections and coinfections with other microorganisms and their influence on the host through a comprehensive approach to laboratory techniques.
One of the main lines of research involves the study of the coinfection of viral hepatitis with the Human Immunodeficiency Virus (HIV), evaluating the impact of coinfection and elimination of hepatitis C on the HIV reservoir, as well as its impact on virus-induced senescence, among others through the use of “omic” technologies.
Our group leads the Multidisciplinary HIV/Hepatitis Coinfection Group (COVIHEP), and maintains collaborations with national and international research groups of excellence, facilitating greater harmonization and quality in the biomedical research carried out. On the other hand, Dr. Briz maintains close collaboration with private companies, promoting intersectoral alliances that represent a competitive advantage.
The activity of this unit focuses on the development and clinical validation of point-of-care diagnostic methodology against liver viruses based on an emerging field, nanotechnology, a line of research that is developed in collaboration with BioAssays SL. Likewise, this unit focuses on delving into the immuno-virological mechanisms underlying viral infections and coinfections with other microorganisms and their influence on the host through a comprehensive approach to laboratory techniques.
One of the main lines of research involves the study of the coinfection of viral hepatitis with the Human Immunodeficiency Virus (HIV), evaluating the impact of coinfection and elimination of hepatitis C on the HIV reservoir, as well as its impact on virus-induced senescence, among others through the use of “omic” technologies.
Our group leads the Multidisciplinary HIV/Hepatitis Coinfection Group (COVIHEP), and maintains collaborations with national and international research groups of excellence, facilitating greater harmonization and quality in the biomedical research carried out. On the other hand, Dr. Briz maintains close collaboration with private companies, promoting intersectoral alliances that represent a competitive advantage.